Overview

Intravitreal and Intracameral DEX in NPDR

Status:
ENROLLING_BY_INVITATION

Trial end date:
2025-06-01

Target enrollment:

Participant gender:

Summary

To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy

Phase:

PHASE3

Details

Lead Sponsor:

Affiliated Hospital of Nantong University

Treatments:

dexamethasone 21-phosphate